Literature DB >> 950959

Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.

M A Heymann, A M Rudolph, N H Silverman.   

Abstract

Inhibition of prostaglandin synthesis constricts the ductus arteriosus in fetal lambs in utero. We administered the inhibitors, aspirin or indomethacin to 18 premature infants with patent ductus arteriosus, and assessed the effects clinically and by echocardiography (left atrial/aortic-root ratio). After aspirin (20 mg per kilogram, every six hours for four doses) the ductus closed permanently in one infant within 24 hours; in another, constriction occurred with clinical improvement, and the third did not respond. In five infants given 0.3 mg per kilogram of indomethacin, complete closure occurred within one day; two of them, who received three doses had an elevated serum creatinine for one week. In one infant the ductus reopened, requiring a second dose of indomethacin 11 days after the first. Ten infants received 0.1 mg per kilogram of indomethacin, and closure occurred within 24 to 30 hours in eight. One had a soft murmur for four days, and one did not respond to two doses of indomethacin. A murmur reappeared after three to seven days in three infants but only one required further treatment. In infants receiving a single dose of 0.3 mg per kilogram, or one or more doses of 0.1 mg per kilogram, renal function was unaltered.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 950959     DOI: 10.1056/NEJM197609022951004

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  89 in total

1.  Clinical profile and management of PDA in neonates.

Authors:  C C Shanthala; P P Maiya; D Vishwanath; N Banakappa; P M Swamy; N Desai; K H Srinivas
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

Review 2.  Patent ductus arteriousus in the premature neonate: current concepts in pharmacological management.

Authors:  C Hammerman; M Kaplan
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

Review 3.  Patent ductus arteriosus: evidence for and against treatment.

Authors:  Ronald I Clyman; Nancy Chorne
Journal:  J Pediatr       Date:  2007-03       Impact factor: 4.406

4.  Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial.

Authors:  Sanju Yadav; Sheetal Agarwal; Arti Maria; Ajay Dudeja; N K Dubey; Puneet Anand; Dinesh Kumar Yadav
Journal:  Pediatr Cardiol       Date:  2014-01-17       Impact factor: 1.655

5.  Trends in Patent Ductus Arteriosus Diagnosis and Management for Very Low Birth Weight Infants.

Authors:  Samantha Ngo; Jochen Profit; Jeffrey B Gould; Henry C Lee
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

6.  Failure of indomethacin to close persistent ductus arteriosus in infants weighing under 1000 grams.

Authors:  H H Ivey; J Kattwinkel; T S Park; L J Krovetz
Journal:  Br Heart J       Date:  1979-03

7.  Ibuprofen-related renal tubular acidosis in pregnancy.

Authors:  Andrew Mallett; Matthew Lynch; George T John; Helen Healy; Karin Lust
Journal:  Obstet Med       Date:  2011-08-23

8.  Persistent ductus arteriosus complicating the respiratory distress syndrome.

Authors:  R W Jones; D Pickering
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

9.  Ibuprofen in very preterm infants impairs renal function for the first month of life.

Authors:  Rachel Vieux; Roxane Desandes; Farid Boubred; Denis Semama; Francis Guillemin; Marie-Christine Buchweiller; Jeanne Fresson; Jean-Michel Hascoet
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

10.  Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice.

Authors:  Hee-Yoon Chang; Joseph Locker; Run Lu; Victor L Schuster
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.